News

In July 2023, the FDA approved dostarlimab-gxly with carboplatin and paclitaxel for the treatment of advanced endometrial cancer in adult patients.

A recent study by Aaron T. Gerds, MD, Cleveland Clinic Taussif Cancer Institute, and colleagues evaluated HCRU, costs, and overall survival for patients with myelofibrosis who receive ruxolitinib treatment.

Researchers investigated how socioeconomic status, race, and primary language spoken at home can affect time to diagnosis for patients with diffuse large B-cell lymphoma (DLBCL).

Researchers conducted a study on the number of patients with endometrial cancer who received adjuvant radiation treatment in the states that implemented further Medicaid expansion.

In a recent study, Soyon Lee, MPH, and John D. Seeger, PhD, Harvard T.H. Chan School of Public Health, Boston, MA, examined the association between race and cancer-specific survival among patients with diffuse large B-cell lymphoma.

Two recent retrospective studies by Toby Eyre, MD, Oxford Cancer and Hematology Centre, Oxford University NHS Foundation Trust, Oxford, UK, and colleagues, and Anthony Mato, MD, MSCE, Director of the CLL Program, University of Pennsylvania,...

Edward R. Scheffer Cliff, MBBS, MPH, Program on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, and colleagues recently evaluated...

Ellen Ritchie, MD, Weill Cornell Medical College, New York, NY, and colleagues recently analyzed patient-reported outcomes (PROs) in myelofibrosis or essential thrombocythemia for patients who participated in the MOST study to measure symptom...

On January 19, 2023, the Food and Drug Administration (FDA) approved zanubrutinib for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This approval was based on the SEQUOIA and ALPINE trials, respectively. The...

In a presentation at the 2023 NCCN Annual Conference, Keith Argenbright, MD, Moncrief Cancer Institute in Fort Worth, TX, and Evelyn González, Fox Chase Cancer Center in Philadelphia, PA, described the benefits of mobile cancer screening...